Carmen de Mendoza

6PUBLICATIONS
17CO-AUTHORS
Gene mappingMicrobial geneticsMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 01, 2024
Low-coverage whole genome sequencing for a highly selective cohort of severe COVID-19 patients.

Renato Santos, Víctor Moreno-Torres, Ilduara Pintos

|May 22, 2023
The slowdown of new infections by human retroviruses has reached a plateau in Spain.

Carmen de Mendoza, Paula Carrizo, Silvia Sauleda

|Jan 30, 2023
Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy.

Vicente Soriano, Victor Moreno-Torres, Ana Treviño

|Jun 01, 2022
Hepatitis C hospitalizations in Spain and impact of new curative antiviral therapies.

José-Manuel Ramos-Rincon, Héctor Pinargote-Celorio, Carmen de Mendoza

|Dec 04, 2020
Inflammatory-Related Clinical and Metabolic Outcomes in COVID-19 Patients.

Maria Martinez-Urbistondo, Alberto Mora-Vargas, Esther Expósito-Palomo

|Oct 10, 2017
Baseline NS5A resistance associated substitutions may impair DAA response in real-world hepatitis C patients.

Itzíar Carrasco, Ana Arias, Laura Benítez-Gutiérrez

Pageof 1